United States · Bill · S
S. 2137 (108th)
Pharmaceutical Market Access Act of 2003
Introduced
26 February 2004
Last action
8 September 2004 · Introduced
Status
Sponsor introductory remarks on measure. (CR S8932-8933)
Sponsors
Sen. Dorgan, Byron L. [D-ND], Sen. Snowe, Olympia J. [R-ME], Sen. Stabenow, Debbie [D-MI], Sen. McCain, John [R-AZ], Sen. Daschle, Thomas A. [D-SD]
Subjects
Healthcare
Source updated
18 August 2025
Summary
Pharmaceutical Market Access Act of 2003 (sic) - Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products). Amends provisions pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product. Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests). Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products. Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 February 2004
Introduced
Introduced in Senate
Source: IntroReferral
26 February 2004
Calendars
Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Source: Calendars
27 February 2004
Calendars
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 436.
Source: Calendars
8 September 2004
Introduced
Sponsor introductory remarks on measure. (CR S8932-8933)
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Placed on Calendar Senate · 27 February 2004 · Download file
Documents
3 official files
Placed on Calendar Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Placed on Calendar Senate (text)
Placed on Calendar Senate · EN · 27 February 2004
Placed on Calendar Senate (PDF)
Placed on Calendar Senate · EN · 27 February 2004
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 26 February 2004
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Dorgan, Byron L. [D-ND] · D · Sponsor
- Sen. Snowe, Olympia J. [R-ME] · R · Sponsor
- Sen. Stabenow, Debbie [D-MI] · D · Sponsor
- Sen. McCain, John [R-AZ] · R · Sponsor
- Sen. Daschle, Thomas A. [D-SD] · D · Sponsor
Related records
- related to → Pharmaceutical Market Access Act of 2003
- related to → Pharmaceutical Market Access Act of 2003
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/senate-bill/2137
- Open data entity: https://api.congress.gov/v3/bill/108/s/2137
- us · 108-s-2137 · source updated 18 August 2025